Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab
Journal of Drugs in Dermatology · 2023
DOI: 10.36849/jdd.7196 ↗At a glance
Fallbericht in Journal of Drugs in Dermatology, 2023. Written by Eric Sanfilippo and 2 co-authors. Major MEDLINE topics: Autoimmune Diseases, Pemphigoid, Bullous. Cited 4 times so far (Crossref).
Abstract (original language)
Bullous pemphigoid (BP) is an autoimmune blistering disease that typically presents with pruritic, tense bullae in elderly patients.1 Several recognized presentations deviate from the classic bullous eruption, and erythrodermic BP, in particular, is thought to be a rare phenomenon. Herein, we present a case of erythrodermic BP in an African American male who initially presented with erythroderma in the absence of tense bullae. There have been no reports on erythrodermic BP in skin of color to our knowledge. The patient rapidly improved after treatment was started with dupilumab. He developed classic tense bullae seen in BP once dupilumab was discontinued.Sanfilippo E, Gonzalez Lopez A, Saardi KM. Erythrodermic bullous pemphigoid in skin of color treated with dupilumab. J Drugs Dermatol. 2023;22(7):685-686. doi:10.36849/JDD.7196. .
Subjects
MeSH terms (MEDLINE)
Substances
Cite
APA
Sanfilippo, E., Gonzalez Lopez, A., & Saardi, K. M. (2023). Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7196
Vancouver
Sanfilippo E, Gonzalez Lopez A, Saardi KM. Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7196
BibTeX
@article{Sanfilippo2023,
author = {Sanfilippo, Eric and Gonzalez Lopez, Adrianna and Saardi, Karl M},
title = {Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab},
journal = {Journal of Drugs in Dermatology},
year = {2023},
doi = {10.36849/jdd.7196}
}
EUVIMED